No Detail Found!

Construction and Immunogenicity of Recombinant Phage T7 Expressing Capsid of Porcine Circovirus Type 2.

Author(s)
Liu Yang Key Laboratory of Pig Industry Sciences, Ministry of Agriculture, Rongchang, Chongqing 402460, China: Chongqing Academy of Animal Science, Rongchang, Chongqing 402460, China
Maixun Zhu Key Laboratory of Pig Industry Sciences, Ministry of Agriculture, Rongchang, Chongqing 402460, China: Chongqing Academy of Animal Science, Rongchang, Chongqing 402460, China
Li-zhi Fu Key Laboratory of Pig Industry Sciences, Ministry of Agriculture, Rongchang, Chongqing 402460, China: Chongqing Academy of Animal Science, Rongchang, Chongqing 402460, China
Shaoqin Zhai Key Laboratory of Pig Industry Sciences, Ministry of Agriculture, Rongchang, Chongqing 402460, China: Chongqing Academy of Animal Science, Rongchang, Chongqing 402460, China
Abstract
Porcine Circovirus type 2 (PCV2) is the causative agent of porcine circovirus disease (PCVD) that is regarded as one of the most important diseases endangering pig industry development. Immunization is one of the most effective ways to prevention and control PCV2 infection. Here, gene encoding capsid protein of a PCV2 from a farm of Chongqing was optimized, synthesized and inserted into the coat protein 10B gene of T7 phage to construct recombinant phage T7-Cap. Capsid protein expressed on the surface of phage T7-Cap was tested using western blot. Anti-PCV2 antibody in the serum was detected after the swine inoculated with T7-Cap. The virus clearance from the serum was assayed by PCR after T-Cap vaccinated pigs were challenged by PCV2. The results showed recombinant phage inserted with the PCV2 capsid gene was successfully constructed. Western blot assay showed that PCV2 capsid was expressed on the surface of phage T7-Cap. Specific anti-PCV2 antibody induced production in the pigs inoculated with T7-Cap, and the PCV2 virus could be cleared from the T7-Cap immunized pigs after they were challenged by PCV2. These findings indicate T7-Cap may be a suitable alternative candidate vaccine of PCVD because it can easily be produced in large scales, cheap and cost-effective.
Publication Details
Page(s) 916-920
Published Journal: International Journal of Agriculture and Biology, Volume: 20, Issue: 4, Year: 2018

Request the full text from PASTIC

References
Clark , J.R.,J.B.March, 2006.Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials,Trends Biotechnol 5 212 -218
Clark , J.R.,K.Bartley,C.D.Jepson,V.Craik,J.B.March, 2011.Comparison of a bacteriophage-delivered DNA vaccine and a commercially available recombinant protein vaccine against hepatitis B,FEMS Immunol. Med 197 -204
Harlow , E. and D.,Lane, 1988.Antibodies: a Laboratory Manual, -
Laemmli , V.K., 1970.Cleavage of structural protein during the assembly of the head of bacteiophage T4,Nature 227 680 -685
Li , C.,D.J.Li,H.Zheng,Y.F.Zhang,R.Q.Zeng,L.Yang, 2016.Isolation, identification and genome sequence analysis of PCV2b, Prog, 10 1 -5
Mahe , D.,P.Blanchard,C.Truong,C.Arnauld,P.L.Cann,R.Cariolet,F.Madec,E.Albina,A.Jestin, 2000.Differential recognition of ORF2 protein from type 1 and type 2 porcine circoviruses and identification of immunorelevant epitopes,J. Gen. Virol. 7 1815 -1824
Manoutcharian , K.,A.Díaz-Orea,G.Acero,E.González,A.D.Aluja,N.Villalobos,E.Gómez-Conde,E.Sciutto, 2004.Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis,Vet 99 11 -24
Meng , X.J., 2013.Porcine circovirus type 2 (PCV2): pathogenesis and interaction with the immune system,Annu. Rev. Anim. Biosci. 1 43 -64
Nawagitgul , P.,S.R.Bolin,H.R.Harms,S.D.Sorden,P.S.Paul, 2000.Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein,J. Gen. Virol. 9 2281 -2287
Opriessnig , T.,H.G.Shen,N.Pal,S.Ramamoorthy,Y.W.Huang,K.M. Lager , N.M.,Beach , P.G.,Halbur and X.J.,Meng, 2011.A liveattenuated chimeric Porcine Circovirus Type 2 (PCV2) vaccine is transmitted to contact pigs but is not upregulated by concurrent infection with Porcine Parvovirus (PPV) and Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) and is efficacious in a PCV2b- PRRSV-PPV challenge model,Clin. Vaccine Immunol 18 1261 -1268
Sambrook , J. and D.W.,Russell, 2001.Molecular Cloning - a Laboratory Manual, 3rd edition, -
Wallgrep , P.,I.M.Brunborg,G.Bergström,F.Wikström,C.Fossum,C.M. Jonassen, 2009.The index herd with PMWS in Sweden: presence of serum amyloid A, circovirus 2 viral load and antibody levels in healthy and PMWS-affected pigs,Acta Vet 51 13 -
Wright , A.,C.H.Hawkins,E.E.Anggard,D.R.Harper, 2009.A controlled clinical trial of a therapeutic bacteriophage preparation in chronico titis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy, Clin, 4 349 -357
Xu , H.,Y.W.Wang,Y.H.Tang,Q.S.Zheng,J.B.Hou, 2013.Construction and immunogenicity of recombinant bacteriophage T7 vaccine expressing M2e peptides of avian influenza virus,Chin. J. Virol. 4 376 -381
Yang , L.,C.Li,S.Q.Zhai,H.Zheng,L.Z.Fu,D.J.Li, 2016.An improved plating assay for determination of phage titer,Afr. J. Biotechnol 23 1078 -1082
0

Citations

0

Downloads

97

Views